Founded in 1998, Illumina reshaped modern genomics by making high throughput DNA sequencing faster, cheaper, and more reliable. Its platforms helped drive the cost curve down, which opened the door to population studies, precision medicine, and routine research applications. Today, Illumina is a benchmark vendor for next generation sequencing technology and workflows.
The company serves academic labs, biopharma, clinical diagnostics providers, and public health programs that require scalable sequencing at high accuracy. Illumina’s appeal rests on proven chemistry, broad application support, and strong data quality, which together make it a default choice for many labs. Its instruments and consumables are widely available, well documented, and supported by a large user community.
Positioned as an end to end ecosystem, Illumina offers instruments, library prep kits, reagents, and analysis software that fit together smoothly. Customers value the combination of throughput, reproducibility, and a clear upgrade path as needs grow. This mix of performance and ecosystem strength is why Illumina remains popular across research and clinical settings.
Key Criteria for Evaluating Illumina Competitors
Choosing an alternative to Illumina means balancing performance, cost, and workflow fit for your specific applications. The best option should meet current needs and scale with future demand. Use the following criteria to compare platforms with confidence.
- Sequencing accuracy and data quality: Look at error rates, Q30 scores, and coverage uniformity. Consistent, high quality data reduces downstream rework and boosts confidence in results.
- Throughput and scalability: Evaluate reads or gigabases per run, runtime, and sample multiplexing. Consider automation compatibility and whether the system can grow with larger studies.
- Total cost of ownership: Compare instrument price, consumables cost per sample or per gigabase, and service contracts. Factor in maintenance, warranties, and expected lifespan.
- Application fit and read characteristics: Check read length, paired end options, and suitability for WGS, RNA seq, metagenomics, single cell, or targeted panels. Match platform strengths to your study design.
- Workflow and ease of use: Assess library prep complexity, hands on time, and turnaround. Simpler workflows reduce training burden and improve lab throughput.
- Software and analysis ecosystem: Review basecalling, secondary analysis, and compatibility with pipelines, LIMS, and cloud tools. Strong ecosystems shorten time to insight.
- Reliability and support: Consider uptime, instrument robustness, and regional field service coverage. Responsive support minimizes downtime and protects study timelines.
- Compliance, security, and data governance: Verify applicable certifications and privacy controls. Clinical or regulated environments require clear policies for data protection and audit readiness.
Top 12 Illumina Competitors and Alternatives
Thermo Fisher Scientific
Thermo Fisher Scientific commands a broad footprint in genomics, serving research and clinical labs with instruments, reagents, and analysis software. Its Ion Torrent sequencing platforms emphasize speed and targeted applications. Many organizations choose Thermo Fisher for end to end workflows that integrate seamlessly across laboratory processes.
- The company offers Ion GeneStudio S5 systems for semiconductor based sequencing, optimized for amplicon and targeted panels with rapid run times and streamlined sample to answer workflows.
- A deep catalog of Oncomine assays, sample prep kits, and automation options supports oncology, infectious disease, and inherited disease applications across translational and clinical research settings.
- Global service, regulatory experience, and established distribution provide strong market presence, which is attractive for multi site labs standardizing methods and support contracts.
- As an Illumina alternative, Thermo Fisher is often selected for rapid targeted sequencing and lower capital thresholds, particularly when throughput needs are modest but turnaround time is critical.
- Integration with qPCR, capillary electrophoresis, and sample extraction enables consolidated procurement and harmonized quality systems, reducing vendor complexity for large labs.
- Ion Torrent chemistry provides fast runs and simplified analysis pipelines, which can shorten validation timelines for focused clinical research panels.
- Comprehensive informatics, including the Ion Reporter ecosystem and cloud options, facilitates variant calling and reporting for predefined gene sets, aligning with diagnostic style workflows.
MGI Tech
MGI Tech, a BGI Group company, markets DNBSEQ platforms that compete directly on cost, throughput, and automation. Its DNA nanoball technology focuses on high data output with low duplication rates. Many regions rely on MGI for scalable sequencing that pairs with integrated lab systems.
- The DNBSEQ portfolio spans benchtop to ultra high throughput instruments, offering flexible flow cell formats that can match diverse project sizes and budgets.
- DNA nanoball array chemistry targets uniform cluster density and reduced index hopping, which appeals to users prioritizing consistency in large cohort studies.
- MGISP automation systems and library prep kits create a coordinated ecosystem, helping labs streamline sample handling and reduce hands on time.
- As an Illumina alternative, MGI is considered for cost per gigabase advantages and versatile throughput bands, which can lower total cost of ownership in population scale studies.
- Strong presence across Asia and expanding footprints in Europe and other regions contribute to a growing install base and third party application support.
- Product categories include whole genome, whole exome, RNA sequencing, and metagenomics kits, along with bioinformatics tools for primary and secondary analysis.
- Collaborations with hospitals and national initiatives highlight suitability for public health surveillance, large biobank sequencing, and clinical research pipelines.
Pacific Biosciences
Pacific Biosciences is renowned for highly accurate long reads that resolve complex genomic regions. Its HiFi chemistry delivers long inserts with high per read accuracy, enabling confident structural variant and haplotype analysis. Researchers turn to PacBio when contiguous assemblies and variant precision matter most.
- The Revio and Sequel IIe systems generate HiFi reads with Q scores suited for comprehensive variant detection, including indels, tandem repeats, and difficult to map loci.
- PacBio excels in de novo assembly, rare disease discovery, pharmacogenomics, and microbial genomics where long range information improves interpretability.
- As an alternative to Illumina, PacBio is chosen when short reads alone cannot resolve repeats, GC rich regions, or complex rearrangements, enhancing both research and translational outcomes.
- Ecosystem support includes compatible library prep kits, targeted enrichment for long fragments, and analysis pipelines like SMRT Link for streamlined variant calling.
- HiFi data supports methylation detection without additional chemistry, enabling integrated epigenetic and sequence analysis from the same run.
- Growing clinical research use cases, including carrier screening and oncology research, broaden market presence beyond basic research.
- Continuous improvements in throughput and cost efficiency have expanded feasibility for population scale long read studies and pangenome projects.
Oxford Nanopore Technologies
Oxford Nanopore Technologies offers real time, portable, and scalable sequencing that spans handheld to population scale systems. Its long read approach captures structural variation and full length transcripts with on instrument basecalling. Many labs value the adaptability of nanopore sequencing for fieldwork and rapid insights.
- Platforms such as MinION, GridION, and PromethION provide flexible throughput, from ad hoc experiments to high volume production environments.
- Nanopore sequencing delivers ultra long reads that can exceed megabase lengths, which simplifies assembly and phasing while capturing complex SVs.
- Real time data streaming enables rapid decision making, including adaptive sampling to enrich targets computationally without wet lab enrichment changes.
- As an Illumina alternative, Oxford Nanopore is considered for portability, speed to result, and long range biology, often in infectious disease surveillance and metagenomics.
- Direct RNA and native DNA options support base modification detection and RNA isoform analysis, reducing sample preparation steps for certain assays.
- A robust developer community, open APIs, and frequent chemistry updates foster innovation and rapid method development.
- Expanding accuracy and Q score improvements have increased suitability for both research grade variant calling and targeted clinical research workflows.
Element Biosciences
Element Biosciences focuses on benchtop short read sequencing with a cost sensitive profile. Its AVITI system uses avidity base chemistry to deliver accuracy and flexible run configurations. Many core facilities evaluate Element to diversify mid throughput capacity without overspending.
- AVITI offers dual independent flow cells, allowing labs to run different applications concurrently and maximize uptime across variable workloads.
- The avidity sequencing approach aims to reduce reagent consumption while maintaining high signal to noise, supporting favorable cost per gigabase.
- As an alternative to Illumina, Element is considered for budget conscious labs seeking high quality short reads in exome, RNA, and targeted applications.
- Library compatibility includes standard Illumina style constructs through adapter kits, simplifying migration of existing assays.
- Software and onboard analysis are designed for ease of use, shortening training time and accelerating method validation for routine pipelines.
- Ongoing collaborations with reagent and informatics partners expand the catalog of validated workflows and supported applications.
- Compact form factor and straightforward maintenance help fit the system into constrained laboratory spaces and shared core environments.
Singular Genomics
Singular Genomics entered the benchtop market with a focus on speed and flexible throughput. The G4 platform emphasizes fast run times and independently addressable lanes. Groups needing quick turnaround with short read accuracy often compare G4 configurations against incumbent systems.
- The G4 instrument supports up to four flow cells that can be started and finished independently, which suits dynamic lab schedules and urgent projects.
- High cycle speeds and rapid chemistry enable same week delivery for common assays such as RNA sequencing, exomes, and targeted panels.
- As an Illumina alternative, Singular appeals to labs that value fast time to result without committing to very high capital systems.
- Compatibility with common library prep workflows reduces friction when porting assays, including established RNA and DNA methods.
- Vendor validated protocols and technical support aim to shorten onboarding, which is useful for new sequencing labs ramping production.
- Data quality targets high accuracy for variant detection in standard read lengths, supporting both discovery and routine profiling studies.
- Ongoing applications development in oncology and single cell library compatibility broadens the platform utility over time.
Ultima Genomics
Ultima Genomics positions itself around dramatically lowering sequencing cost at scale. Its high throughput platform focuses on population level studies and large clinical research cohorts. Early adopters test Ultima when cost per genome is a primary constraint.
- The system uses an open fluidics design intended to increase imaging efficiency and reduce reagent consumption, which can improve cost metrics.
- Throughput targets are aligned with large whole genome sequencing programs, enabling rapid accumulation of cohort level data.
- As an Illumina alternative, Ultima is considered where budget limits restrict the scope of genomics, particularly in biobanks and public health projects.
- Partnership based method development brings collaborators into chemistry and software refinement, accelerating validation of common pipelines.
- The company emphasizes compatibility with standard analysis stacks, easing integration into existing bioinformatics infrastructures.
- Continuing improvements in read quality and run stability aim to broaden application breadth from WGS to exome and RNA sequencing.
- Strategic reagent pricing and service models are positioned to lower total cost of ownership for high volume sequencing centers.
Roche
Roche maintains a strong presence in genomics through library preparation, target enrichment, and oncology assay portfolios. Its KAPA and AVENIO product families are widely used in translational research. Institutions value Roche for clinical expertise and quality systems.
- KAPA library prep and target capture kits support DNA, RNA, and hybridization based enrichment with reproducible performance across automation platforms.
- AVENIO solutions address circulating tumor DNA analysis, providing validated panels and workflows for liquid biopsy research.
- As an Illumina alternative, Roche competes at the assay layer, allowing labs to standardize on Roche chemistry while running on multiple sequencer brands.
- Roche Diagnostics infrastructure and regulatory experience support labs pursuing clinical research and assay development with stringent quality requirements.
- Broad automation compatibility, including liquid handlers and integrated prep systems, helps scale throughput without sacrificing consistency.
- Comprehensive technical documentation and lot to lot control appeal to regulated environments and longitudinal studies.
- Roche’s investments in oncology, infectious disease, and genetics provide a pipeline of content driven panels that shorten development cycles.
QIAGEN
QIAGEN is recognized for sample to insight workflows that combine extraction, library prep, and bioinformatics. The company supports numerous NGS applications with QIAseq technologies. Labs choose QIAGEN to unify chemistry and analysis across research and clinical research projects.
- QIAseq panels and Unique Molecular Index strategies enhance error correction for low frequency variant detection, which is valuable in oncology and liquid biopsy research.
- Sample processing instruments such as QIAsymphony and QIAcube standardize preanalytical steps, improving reproducibility across batches.
- As an Illumina alternative, QIAGEN competes through end to end kits that run on multiple sequencing platforms, reducing lock in to any single vendor.
- CLC Genomics Workbench and Ingenuity variant interpretation extend into secondary and tertiary analysis, aligning wet lab and informatics.
- A large installed base across molecular labs provides community support, training resources, and validated protocols for common assays.
- Content rich panels for human genetics, infectious disease, and microbiome allow rapid deployment of targeted sequencing with proven performance.
- Regulatory grade documentation and quality management compatibility ease the path for labs operating under clinical research standards.
Agilent Technologies
Agilent Technologies is a leader in target enrichment and genomic QC. Its SureSelect portfolio and QC instruments are staples in many NGS labs. Teams adopt Agilent to enhance capture efficiency and streamline sample quality control.
- SureSelect hybrid capture solutions offer broad content and customizable designs, enabling precise enrichment strategies for exomes and targeted panels.
- QC instruments such as TapeStation and Fragment Analyzer deliver rapid sizing and quality metrics, reducing failed runs and rework.
- As an Illumina alternative, Agilent competes at the chemistry and array levels, providing microarray options when sequencing depth is not required.
- Agilent microarrays support copy number and gene expression studies at scale, which can be cost effective for certain cohort analyses.
- Automation with Magnis and Bravo platforms simplifies library prep and capture, promoting consistency across high throughput labs.
- Strong technical support and extensive application notes help labs optimize capture performance across diverse sample types.
- Compatibility with standard library structures allows straightforward integration with Illumina style pipelines and other sequencers.
10x Genomics
10x Genomics is synonymous with single cell and spatial omics. Its platforms generate libraries that reveal cellular heterogeneity and tissue architecture. Researchers weigh 10x solutions when biological resolution matters more than bulk throughput.
- Chromium enables high throughput single cell RNA, immune profiling, and multiome assays, creating libraries compatible with common short read sequencers.
- Visium and Xenium deliver spatial transcriptomics and in situ gene expression, expanding beyond sequencing into imaging linked assays.
- As an Illumina alternative, 10x competes for project budgets by offering orthogonal insights that short read bulk sequencing cannot provide.
- Comprehensive software, including Cell Ranger and Space Ranger, standardizes analysis with clear documentation and community support.
- Validated wet lab workflows reduce development time for complex assays, accelerating adoption in core facilities and consortium projects.
- Broad partnerships across oncology, neuroscience, and immunology showcase application depth and reproducibility in high impact studies.
- Continual chemistry improvements increase cell capture efficiency, sensitivity, and gene detection, improving data quality over successive product generations.
Bionano Genomics
Bionano Genomics specializes in optical genome mapping for structural variation analysis. Its Saphyr system images ultra long DNA molecules to detect large rearrangements with high confidence. Many cytogenetics and research labs adopt Bionano to complement or replace certain karyotyping and FISH workflows.
- Optical mapping excels at detecting insertions, deletions, inversions, and translocations at sizes that can be challenging for short reads.
- As an Illumina alternative, Bionano is chosen when the primary goal is structural variant discovery and genome wide cytogenetic profiling.
- Saphyr throughput supports cohort level studies, enabling consistent detection of recurrent structural events across many samples.
- Sample prep for ultra high molecular weight DNA is supported by optimized kits and protocols that preserve molecule length.
- Software pipelines provide automated SV calling and visualization, aiding interpretation in constitutional genetics and oncology research.
- Integration with sequencing data enables hybrid assemblies and comprehensive variant catalogs that improve diagnostic yield in research settings.
- Adoption in academic medical centers and reference labs underscores real world utility for complex genome analysis.
Complete Genomics
Complete Genomics, part of the MGI family, provides sequencing technology and services based on DNA nanoball arrays. It is best known for whole genome sequencing workflows and data analysis expertise. Organizations consider Complete Genomics for turnkey large scale projects.
- Technology innovations in patterned arrays and rolling circle amplification underpin high output whole genome sequencing with consistent performance.
- As an Illumina alternative, Complete Genomics appeals to users seeking contract sequencing and standardized pipelines without building in house capacity.
- Service models can accelerate population studies, allowing rapid data generation with predefined quality metrics and deliverables.
- Data analysis experience supports variant calling and annotation at scale, easing the computational burden on customer teams.
- Partnerships with research consortia demonstrate capability to deliver large datasets on schedule while maintaining quality controls.
- Compatibility with common downstream bioinformatics simplifies integration with established storage and analysis platforms.
- Focus on whole genomes aligns with studies in rare disease, cancer research, and population genetics where comprehensive variant catalogs are required.
BGI
BGI operates globally as a genomics research organization and technology provider with strong sequencing capabilities. It serves public health, agriculture, and clinical research markets through platforms and services. Many institutions partner with BGI for scale, logistics, and project management in large programs.
- BGI offers high throughput sequencing services and deploys DNBSEQ technology in facilities worldwide, enabling rapid expansion of big studies.
- As an Illumina alternative, BGI is considered for competitive pricing and the ability to handle large multi site logistics with consistent processes.
- Project support spans study design, sample handling, sequencing, and bioinformatics, reducing coordination overhead for sponsors.
- Application breadth includes whole genome and exome sequencing, transcriptomics, metagenomics, and non invasive prenatal research.
- Global operations and experience with surveillance initiatives make BGI a partner for urgent public health sequencing needs.
- Established procurement channels and standardized deliverables can shorten contracting and initiation timelines for international projects.
- Ongoing technology development and ecosystem partnerships expand method options and data quality improvements across offerings.
Top 3 Best Alternatives to Illumina
Pacific Biosciences (PacBio)
PacBio stands out for highly accurate HiFi long reads that combine substantial read lengths with industry leading base quality, which is ideal for resolving complex regions and structural variants. Key advantages include exceptional consensus accuracy, strong performance for de novo assembly and isoform sequencing, and improving throughput with modern systems that support large population and translational studies. It best suits researchers who prioritize precision in variant calling, comprehensive genome or transcriptome reconstruction, and applications where long, high fidelity reads materially improve scientific outcomes.
Oxford Nanopore Technologies (ONT)
Oxford Nanopore excels with real time, scalable, and portable sequencing that delivers ultra long reads and native modification detection for DNA and RNA. Core advantages include rapid library preparation, flexible device options from handheld to high throughput instruments, and adaptive sampling that enables on the fly enrichment of targets for faster answers. It is a strong fit for teams needing fast turnaround or field deployable workflows, as well as projects focused on structural variation, metagenomics, transcript isoforms, or methylation profiling at scale.
MGI Tech (DNBSEQ)
MGI provides a compelling short read alternative through DNBSEQ platforms that offer high throughput, competitive cost per gigabase, and low duplication rates for efficient data generation. Advantages include a broad instrument portfolio from benchtop to production scale, automation friendly workflows, and strong performance across WGS, WES, RNA sequencing, and large cohort studies. It suits core facilities and high volume labs seeking to lower total cost of ownership, diversify platform risk, and run population scale projects with consistent quality and throughput.
Final Thoughts
Illumina remains a leader, yet many strong alternatives are available that rival or exceed its capabilities in specific areas such as long reads, turnaround time, and total cost per sample. PacBio, Oxford Nanopore, and MGI each bring distinct strengths, from HiFi accuracy and real time portability to economical high throughput short reads. The right choice depends on your priorities, including read length needs, accuracy targets, budget, sample types, and required speed.
Start by mapping platform strengths to your study design, then factor in library prep complexity, downstream analysis tools, and support or service coverage. Many labs succeed with a mixed portfolio, pairing complementary platforms to balance cost, quality, and time to insight. With clear goals and realistic throughput planning, you can select an alternative that delivers dependable results and long term value.
